1x phenylmethanesulfonyl fluoride (Cell Signaling Technology Inc)
96
Structured Review
Cell Signaling Technology Inc
1x phenylmethanesulfonyl fluoride
1x Phenylmethanesulfonyl Fluoride, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1129 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1x+pmsf/PMSF/bio_rxiv__64898__2026__01__01__697286-281-24-28
Average 96 stars, based on 1129 article reviews
1x Phenylmethanesulfonyl Fluoride, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1129 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1x+pmsf/PMSF/bio_rxiv__64898__2026__01__01__697286-281-24-28
Average 96 stars, based on 1129 article reviews
1x phenylmethanesulfonyl fluoride - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
other:Article Title: Disruption of H3K36 methylation provokes cellular plasticity to drive aberrant glandular formation and squamous carcinogenesis. Article Snippet: Short article Disruption of H3K36 methylation provokes cellular plasticity to drive aberrant glandular formation and squamous carcinogenesis Lysis:Article Title: Comparative transcriptome profile of mouse macrophages treated with the RhoA/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119). Article Snippet: Macrophages play a crucial role in, the currently uncurable, chronic rejection of transplants.. In rodent transplantation models, inhibition of the RhoA/Rock pathway disrupts actin-related functions of macrophages, preventing them from entering the graft, and reducing vessel occlusion, fibrosis, and chronic rejection.. Among RhoA/Rock inhibitors that inhibit chronic rejection in mouse transplantation are Y27632, Fingolimod, and Rezurock. Protease Inhibitor:Article Title: Comparative transcriptome profile of mouse macrophages treated with the RhoA/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119). Article Snippet: Macrophages play a crucial role in, the currently uncurable, chronic rejection of transplants.. In rodent transplantation models, inhibition of the RhoA/Rock pathway disrupts actin-related functions of macrophages, preventing them from entering the graft, and reducing vessel occlusion, fibrosis, and chronic rejection.. Among RhoA/Rock inhibitors that inhibit chronic rejection in mouse transplantation are Y27632, Fingolimod, and Rezurock. Article Title: Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells. Article Snippet: Inhibiting epigenetic modulators can transcriptionally reactivate transposable elements (TEs).. These TE transcripts often generate unique peptides that can serve as immunogenic antigens for immunotherapy.. Here, we ask whether TEs activated by epigenetic therapy could appreciably increase the antigen repertoire in glioblastoma, an aggressive brain cancer with low mutation and neoantigen burden. Article Title: STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malaria Article Snippet: .. Cells were lysed with 500 μl RIPA buffer (Cell Signaling Technology, Danvers, MA) with Article Title: Apoptotic pathway protein expression variance in metal oxide and quantum dot treated HeLa cells Article Snippet: .. After incubation in the various treatments, cell lysate was extracted from the cells using a 1X protease inhibitor cocktail (Halt TM from Thermo Scientific) with additional Incubation:Article Title: Apoptotic pathway protein expression variance in metal oxide and quantum dot treated HeLa cells Article Snippet: .. After incubation in the various treatments, cell lysate was extracted from the cells using a 1X protease inhibitor cocktail (Halt TM from Thermo Scientific) with additional |